These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17276898)

  • 41. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.
    Ishii K; Hasegawa H; Nagata N; Mizutani T; Morikawa S; Suzuki T; Taguchi F; Tashiro M; Takemori T; Miyamura T; Tsunetsugu-Yokota Y
    Virology; 2006 Aug; 351(2):368-80. PubMed ID: 16678878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
    Tseng CT; Sbrana E; Iwata-Yoshikawa N; Newman PC; Garron T; Atmar RL; Peters CJ; Couch RB
    PLoS One; 2012; 7(4):e35421. PubMed ID: 22536382
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.
    Du L; Zhao G; Chan CC; Sun S; Chen M; Liu Z; Guo H; He Y; Zhou Y; Zheng BJ; Jiang S
    Virology; 2009 Oct; 393(1):144-50. PubMed ID: 19683779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.
    Gai WW; Zhang Y; Zhou DH; Chen YQ; Yang JY; Yan HM
    Virol Sin; 2011 Apr; 26(2):81-94. PubMed ID: 21468931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines.
    See RH; Petric M; Lawrence DJ; Mok CPY; Rowe T; Zitzow LA; Karunakaran KP; Voss TG; Brunham RC; Gauldie J; Finlay BB; Roper RL
    J Gen Virol; 2008 Sep; 89(Pt 9):2136-2146. PubMed ID: 18753223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
    Miyoshi-Akiyama T; Ishida I; Fukushi M; Yamaguchi K; Matsuoka Y; Ishihara T; Tsukahara M; Hatakeyama S; Itoh N; Morisawa A; Yoshinaka Y; Yamamoto N; Lianfeng Z; Chuan Q; Kirikae T; Sasazuki T
    J Infect Dis; 2011 Jun; 203(11):1574-81. PubMed ID: 21592986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.
    Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.
    Zhu Y; Yu D; Han Y; Yan H; Chong H; Ren L; Wang J; Li T; He Y
    Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33036961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity.
    Du L; Zhao G; Chan CC; Li L; He Y; Zhou Y; Zheng BJ; Jiang S
    Viral Immunol; 2010 Apr; 23(2):211-9. PubMed ID: 20374001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus.
    Yasui F; Kohara M; Kitabatake M; Nishiwaki T; Fujii H; Tateno C; Yoneda M; Morita K; Matsushima K; Koyasu S; Kai C
    Virology; 2014 Apr; 454-455():157-68. PubMed ID: 24725942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children].
    Cao L; Wang TY; Chen HZ; Qian Y; Chen BW; Fang P; Sun YX; Zhu RN; Deng J; Zhao LQ; Mi J; Zhang T
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):840-4. PubMed ID: 15631713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L; Zhao G; Lin Y; Sui H; Chan C; Ma S; He Y; Jiang S; Wu C; Yuen KY; Jin DY; Zhou Y; Zheng BJ
    J Immunol; 2008 Jan; 180(2):948-56. PubMed ID: 18178835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses.
    Tsunetsugu-Yokota Y; Ato M; Takahashi Y; Hashimoto S; Kaji T; Kuraoka M; Yamamoto K; Mitsuki YY; Yamamoto T; Oshima M; Ohnishi K; Takemori T
    Jpn J Infect Dis; 2007 May; 60(2-3):106-12. PubMed ID: 17515642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
    Spruth M; Kistner O; Savidis-Dacho H; Hitter E; Crowe B; Gerencer M; Brühl P; Grillberger L; Reiter M; Tauer C; Mundt W; Barrett PN
    Vaccine; 2006 Jan; 24(5):652-61. PubMed ID: 16214268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.
    Yang ZY; Kong WP; Huang Y; Roberts A; Murphy BR; Subbarao K; Nabel GJ
    Nature; 2004 Apr; 428(6982):561-4. PubMed ID: 15024391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
    He Y; Zhou Y; Wu H; Luo B; Chen J; Li W; Jiang S
    J Immunol; 2004 Sep; 173(6):4050-7. PubMed ID: 15356154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.